Evidence map›Paper›PMID 42791883›Full record

ArticleBioengineering (Basel, Switzerland)2026

DiAbot: A Conversational AI System Coupling Large Language Models with an Interpretable Decision Tree for CDR-Style Dementia Screening.

Hala Alshamlan

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Hala AlshamlanDepartment of Information Technology, College of Computer and Information Sciences, King Saud University, P.O. Box 51178, Riyadh 11543, Saudi Arabia.ORCID 0000-0002-8427-5292

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease and related dementias are projected to affect more than 150 million people worldwide by 2050. Early staging with validated instruments such as the Clinical Dementia Rating (CDR) scale is essential for timely intervention, yet access to clinician-administered CDR assessment remains constrained by workforce, time, and geographic barriers. This study complements a previously published machine learning pipeline for Alzheimer's disease prediction by addressing the downstream task of dementia staging. Because the global CDR score is already derived from the six sub-domain ratings through an established rule-based procedure, the contribution reported here lies not in discovering that mapping but in encoding it in a transparent, deployable form: an explainable decision tree classifier embedded in DiAbot, a large-language-model-fronted conversational system that supports self-administered CDR-style assessment. We extracted 13,453 CDR records from the Alzheimer's Disease Neuroimaging Initiative (ADNI), removed administrative variables, invalid entries, and missing rows (final n = 13,290), and trained decision tree classifiers under two impurity criteria, Information Gain and Gini Index, using a 70/30 stratified record-level hold-out and ten-fold stratified record-level cross-validation. This classifier-level evaluation uses the six domain scores as recorded during ADNI's clinician-administered assessment, not scores elicited by the DiAbot chatbot; the trained classifier was separately embedded in a web application in which a prompt-engineered large language model conducts a CDR-style interview and normalizes responses to ordinal domain scores, but the end-to-end accuracy of that full conversational pipeline (chatbot elicitation through to final CDGLOBAL) has not yet been measured, and is not what the headline accuracy figures below report. The Information Gain Decision Tree reproduced the established mapping from the six CDR sub-domain scores to the CDGLOBAL with 99.86% accuracy under the record-level hold-out protocol (matching macro-averaged precision, recall, and F1-score), with a ten-fold record-level cross-validated mean of 99.81% (SD 0.07); this result represents fidelity to the established CDR scoring rule rather than independent dementia-diagnosis accuracy. Gini-based trees performed almost identically (99.79% hold-out, 99.74% cross-validated). Memory dominated feature importance, consistent with its role as the primary domain in the official CDR scoring algorithm. Residual misclassifications were confined to adjacent CDR stages. Because the CDGLOBAL is deterministically derived from the six sub-domain scores, these figures should be read throughout as evidence of high-fidelity reconstruction of the established CDR scoring relationship, not as general dementia-diagnosis accuracy comparable to imaging- or biomarker-based classifiers; further, participant-independent generalization remains unverified under the record-level protocol evaluated here. An interpretable classifier embedded in a conversational front-end can nonetheless make standardized CDR-style staging more widely accessible while preserving clinical inspectability; the resulting system is positioned as a screening-stage adjunct to, and not a replacement for, clinician-administered CDR assessment.

Indexed as

ADNIAlzheimer’s diseasebioengineeringCDRClinical Dementia Ratingconversational agentdecision treedementia stagingexplainable AIlarge language model

Identifiers

PMID42791883
PMCPMC13603528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.